SMARCB1 and rhabdoid tumor: Transcriptome analyses aligned SMARCA4‐UTs more closely with SMARCA4‐mutated SCCOHTs and SMARCB1‐inactivated malignant rhabdoid tumors (MRTs) rather than conventional NSCLCs.18